Back to Results
First PageMeta Content
Pharmacology / Food and Drug Administration / Pharmaceutical industry / Drug safety / Risperidone / Abbreviated New Drug Application / Bioequivalence / New Drug Application / Clinical research / Pharmaceutical sciences / Research


Federal Register / Vol. 80, NoWednesday, May 27, Notices the Administration for Children and Families. 4730, Silver Spring, MD 20993–0002, 301–796–5850.
Add to Reading List

Document Date: 2015-05-27 10:31:38


Open Document

File Size: 172,66 KB

Share Result on Facebook

City

Rockville / /

Company

Johnson & Johnson Pharmaceutical Research and Development LLC / Public Comment Request Health Resources / /

/

Facility

Parklawn Building / Hillandale Building / /

IndustryTerm

abbreviated new drug applications / /

Organization

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Administration for Children and Families / Division of Drug Information / Division of Dockets Management / Services Administration / Availability AGENCY / FDA / office of Management and Budget / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources / Health Resources and Services Administration / /

Person

Silver Spring / Robert Sargis / Leslie Kux / /

Position

HRSA Information Collection Clearance Officer / Clearance Officer / Governor / Associate Commissioner for Policy / /

Product

Long-Acting Injection / Risperidone / Risperdal Consta / /

ProvinceOrState

Maryland / /

Technology

http / /

URL

http /

SocialTag